Loading…
Loading…
HART (NYLI Healthy Hearts ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See exactly how HART's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HART and 80,000+ other tickers.
This fund employs a passive, indexing-based investment strategy, aiming to replicate the performance of its target index. The benchmark index was developed by IndexIQ LLC, with Candriam Belgium S.A. providing consultation. It encompasses securities issued by large, medium, and small-capitalization companies trading in both U.S. and various global markets. Notably, while it includes a broad range of international equities, the index specifically excludes those from emerging markets located in China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia, and the United Arab Emirates.
Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some popular drugs with pharmaceutical companies.
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
The healthcare sector, the second-largest sector allocation in the S&P 500, performed significantly less poorly than the broader market in 2022 and that relative sturdiness has some market observers optimistic about the group's 2023 prospects.
With just two trading days left in 2022, it's safe to say the healthcare sector was significantly less bad than the broader market. As of December 27, the S&P 500 Health Care Index was down just 2.2% year-to-date compared to nearly 19% for the S&P 500.
With compelling long-term opportunities available across multiple industry groups, healthcare has the makings of a 2023 redemption, potentially boding well for exchange traded funds such as the IQ Healthy Hearts ETF (HART).